Health and Cosmetics Breakthrough Through Advanced Chemistry

 
Our unique platform enables us to develop safer, more effective active ingredients for revolutionary skincare and health products. Our patented compounds, licensed globally, are reshaping standards in the medical and cosmetics industry.
 
Download our latest Investor Presentation.
 
Download

TSX-V: SBM
FSE: ZSB | OTC: SRBCF
Howard J. Verrico, MD
Founder, Sirona Biochem
CEO and Chairman of the Board

Welcome to Sirona Biochem

Sirona Biochem’s strategy is to license or sell patented compounds to leading global companies in return for up-front fees, milestone fees and ongoing royalty payments.

divider
We proudly announce the trademarking of our groundbreaking anti-aging and anti-wrinkle molecule, TFC-1326, as GlycoProteMim™. Sirona Biochem is now engaging industry experts to chart the most effective course for commercializing GlycoProteMim™.
divider

Exclusive Interview

Dr. Géraldine Deliencourt-Godefroy shares insights on the planned commercialization of GlycoProteMim™ through Sirona Laboratories in an exclusive interview with the Investing News Network.

Go In-Depth

Our Investor's Presentation provides a clear overview of Sirona Biochem, its operations, technology and other information relevant to prospective investors.

DOWNLOAD



TSX-V: SBM

TSX Venture Exchange

FSE: ZSB

Frankfurt Stock Exchange

OTC: SRBCF

OTCQB Exchange

About Sirona Biochem

Sirona Biochem is a cosmetic ingredient and drug discovery firm with a proprietary technology. Through its wholly-owned French Subsidary TFChem, the Company specialises in stabilising carbohydrate moleclues with the goal of improving efficiacy and safety.

divider
Our world class team is comprised of award winning scientists who have worked for Fortune 500 companies such as Sanofi, GSK and Bayer.
divider
Geraldine Deliencourt-Godefroy, PhD
Founder TFChem
Chief Scientific Officer

Our Proprietary Technology

Sirona's Breakthrough Chemistry Technology is the solution to unstable carbohydrate molecules.

The chemistry strengthens the bond of the molecules, resulting in increased stability and efficacy.

Our technology has received more than $8M CAD in grants from the French Government

Sirona has 83 approved and pending patents globally.

Carbohydrate molecules are unstable by nature

Sirona’s Technology stabilizes carbohydrate molecule

Our Pipeline

Cosmetic Products
TFC-1067
Dark Spot Corrector
TFC-1326
Anti-Aging
(TBA)
Cellulite Treatment
Pharmaceutical Products
Anti-Viral

Sirona Biochem has invested extensively in developing its products to meet the needs of patients and industry partners.

The compounds created through our proprietary platform go through rigorous tests and regulatory scrutiny to verify their safety and efficacy.

Sirona Biochem is traded on:

TSX-V: SBM
FSE: ZSB
OTC: SRBCF

Our Partners

AbbVie
Stonegate Healthcare
WuXi AppTec
Polepharma
Insitut National des sciences appliquees de Rouen
Global Beauty Consulting